Bulis Veronica Sanchez
- SEC CIK
- 0002095702
In the past year, 5 open-market sale filings worth $96.9K and no purchases.
Current role at each company
- LYEL Lyell Immunopharma, Inc.VP, Corporate Controlleras of Aug 11, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $96.9K
- 5 filings
- Net
- −$96.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bulis Veronica Sanchez as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 (view filing)4:21 PM ET | Aug 10 | 1 day | Bulis Veronica SanchezVP, Corporate Controller | SSale | −621 | $14.34 | −$8.91K | −4.0%14.8K after | |
| Jun 15, 2026 (view filing) | May 11 | 35 daysLate | Bulis Veronica SanchezVP, Corporate Controller | SSale | −217 | $18.91 | −$4.10K | −1.4%15.4K after | |
| Feb 11, 2026 (view filing) | Feb 10 | 1 day | Bulis Veronica SanchezVP, Corporate Controller | SSale | −254 | $23.12 | −$5.87K | −1.6%15.6K after | |
| Jan 6, 2026 (view filing) | Dec 24-30, 2025 | 13 daysLate | Bulis Veronica SanchezVP, Corporate Controller | SSale | −2.07K | $35.80 | −$74.2K | −22.5%7.14K after | 2 lots |
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Bulis Veronica SanchezVP, Corporate Controller | SSale | −239 | $16.10 | −$3.85K | −2.5%9.21K after |